Lung cancer screening with low-dose CT can save lives. This European Union (EU) position
statement presents the available evidence and the major issues that need to be addressed …

Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However,
the past 10 years have seen important advances in treatment and diagnosis which have …

Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Background The diagnosis and staging of lung cancer is an important process that identifies
treatment options and guides disease prognosis. We aimed to assess endobronchial …

BACKGROUND Lung cancer kills more people than any other cancer in the UK (5-year
survival< 13%). Early diagnosis can save lives. The USA-based National Lung Cancer …

Background A major determinant of treatment offered to patients with non‐small cell lung
cancer (NSCLC) is their intrathoracic (mediastinal) nodal status. If the disease has not spread …

The British Thoracic Society guideline for the investigation and management of pulmonary
nodules is published as a supplement to this edition of the journal. It provides …

The International Association for the Study of Lung Cancer (IASLC) Board of Directors
convened a computed tomography (CT) Screening Task Force to develop an IASLC position …

Introduction For appropriately staged non-small cell lung cancer (NSCLC) surgical resection
can dramatically improve survival, but some may not be offered this treatment because of …

Objective The current study aimed to identify the barriers to participation among high-risk
individuals in the UK Lung Cancer Screening (UKLS) pilot trial. Setting The UKLS pilot trial is a …